The Procter & Gamble Company

NYSE:PG Voorraadrapport

Marktkapitalisatie: US$332.3b

Procter & Gamble Toekomstige groei

Future criteriumcontroles 2/6

Procter & Gamble zal naar verwachting groeien in winst en omzet met respectievelijk 3.8% en 3.1% per jaar. De winst per aandeel zal naar verwachting groeien met 4.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 34.3% zijn.

Belangrijke informatie

3.8%

Groei van de winst

4.57%

Groei van de winst per aandeel

Household Products winstgroei4.6%
Inkomstengroei3.1%
Toekomstig rendement op eigen vermogen34.32%
Dekking van analisten

Good

Laatst bijgewerkt14 May 2026

Recente toekomstige groei-updates

Analyseartikel Aug 06

The Procter & Gamble Company (NYSE:PG) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

NYSE:PG 1 Year Share Price vs Fair Value Explore Procter & Gamble's Fair Values from the Community and select yours The...

Recent updates

Narratiefupdate May 04

PG: Brand Partnerships And Product Pipeline Will Support Future Shareholder Returns

Analysts have trimmed their Procter & Gamble price target slightly to about $164.09, reflecting modestly lower assumptions for revenue and profit margins while applying a slightly higher future P/E outlook. What's in the News P&G maintained fiscal 2026 guidance, with all-in sales growth expected in a 1% to 5% range and diluted EPS growth targeted in a 1% to 6% range versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).
Seeking Alpha Apr 25

Procter & Gamble: Fundamentals Are Solid, But The Price Is Too High - Downgrading From Buy To Hold

Summary Procter & Gamble is downgraded from buy to hold due to macroeconomic headwinds and valuation concerns. PG continues to deliver robust, broad-based organic sales growth of 3%, with strength in both volume and pricing. The company’s growth is well-diversified across regions and product categories, underscoring resilience despite poor consumer confidence. Current valuation does not adequately reflect heightened macro uncertainty, making a hold rating more justifiable at this time. Read the full article on Seeking Alpha
Nieuw narratief Apr 24

Procter & Gamble (PG): The Beauty-Driven Beat and the Resilience of Staples

Procter & Gamble (PG) , the global vanguard of consumer staples, enters the afternoon of Friday, April 24, 2026 , as a beacon of stability following its Q3 Fiscal 2026 earnings report released this morning. The Cincinnati-based giant delivered a solid "beat-and-raise" performance, reporting Core EPS of $1.59 , surpassing the Wall Street consensus of $1.56.
Narratiefupdate Apr 20

PG: Buybacks And Brand Partnerships Will Support Future Shareholder Returns

Analysts have slightly reduced their price target on Procter & Gamble to $164.18 from $166.95, reflecting modestly lower assumptions for revenue growth, profit margins, fair value, and future P/E multiples. What's in the News P&G revised its fiscal 2026 diluted EPS growth outlook to a range of 1% to 6%, from a prior range of 3% to 9%, citing higher non core restructuring charges, while keeping all in sales growth guidance at 1% to 5% versus the prior year (Corporate guidance).
Narratiefupdate Apr 05

PG: Share Repurchases And Premium Portfolio Refresh Will Support Future Returns

Analysts have slightly reduced their average price target for Procter & Gamble to about $167 from $168, reflecting updated views on margins and forward P/E assumptions while keeping core growth expectations largely intact. What's in the News OLAY shared new skin aging research at the 2026 American Academy of Dermatology meeting, focusing on cell adhesion as a key factor in visible aging and applying these findings to peptide based products across the Regenerist line and the new Regenerist Treatments collection (Product announcement).
Narratiefupdate Mar 22

PG: Product Refresh And Buybacks Will Support Future Earnings Resilience

Analysts kept their Procter & Gamble price target steady at $168. This reflects largely unchanged views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.
Narratiefupdate Mar 08

PG: Brand Refresh And Buybacks Will Support Stable Earnings Outlook

Analysts have maintained their Procter & Gamble price target at $168, reflecting unchanged assumptions around revenue growth, profit margins, and future P/E. This suggests that recent research has not materially shifted their valuation view.
Narratiefupdate Feb 21

PG: Brand Activity And Buybacks Will Support Stable Margins And Outlook

Analysts have nudged their price target for Procter & Gamble higher to $168.00 from $167.45, reflecting updated assumptions for revenue growth, slightly higher profit margins and a marginally lower future P/E multiple. What's in the News Tide launched Tide evo, a 100% concentrated, waterless laundry tile with six cleaning layers and no plastic bottles, positioned to address demand for products that align with hygiene and sustainability preferences in the U.S. (Product related announcement) Head & Shoulders introduced BARE Itchy Scalp Relief Serum, aimed at providing clinically tested dandruff protection and itch relief between washes, with a nationwide U.S. launch planned for January 2026.
Narratiefupdate Feb 07

PG: Premium Brand Extensions And Stable Margins Will Support A Balanced Outlook

Analysts have nudged their price target on Procter & Gamble slightly higher to US$167.45 from about US$165.32, reflecting updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E. What's in the News Old Spice launched the Spice Alchemist collection, a premium cologne-infused deodorant, body wash and body mist line positioned against high end fragrances.
Narratiefupdate Jan 25

Q2 2026 Update

Update narrative with most recent financial statements.
Narratiefupdate Jan 23

PG: Share Repurchases And Margin Pressures Will Shape A Balanced Outlook

Analysts have trimmed their price target on Procter & Gamble to US$165 from US$168, citing updated views on revenue growth, profit margins, and the future P/E multiple. What's in the News P&G updated its fiscal 2026 guidance, keeping all in sales growth for the year in a range of 1% to 5% versus the prior year, while lowering the diluted EPS growth outlook to 1% to 6% from the previous 3% to 9% range, citing higher non core restructuring charges versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).
Narratiefupdate Jan 07

PG: Share Repurchase Will Support Future Upside With Stable Long Term Outlook

Narrative Update on Procter & Gamble The analyst price target for Procter & Gamble has shifted slightly, with updated assumptions around fair value at about $168.13, discount rate at 6.96%, revenue growth at roughly 3.12%, profit margin near 19.58%, and future P/E around 26.08x, as analysts fine tune their models on the company. What's in the News Pantene is partnering again with social media creator Alix Earle to promote the Abundant & Strong 3-Step System, including limited-edition Alix x Pantene Kits that bundle the three products with a free cosmetics bag and hairbrush for a limited time (product-related announcement).
Narratiefupdate Dec 16

PG: Share Repurchase Will Support Future Upside Amid Stable Long Term Outlook

Analysts have nudged their price target for Procter & Gamble slightly lower to approximately $168.50 from about $169.05, reflecting modestly softer long term revenue growth expectations that are only partially offset by a marginally improved profit margin outlook and a slightly lower assumed future valuation multiple. What's in the News Pantene launched the Abundant & Strong Collection, a three step system clinically shown to reduce hair loss by up to 85% by targeting scalp oxidative stress with a Pro Vitamin Complex plus Niacinamide technology.
Narratiefupdate Dec 02

PG: Share Repurchase And New Collections Will Drive Continued Momentum

Procter & Gamble's analyst price target remains unchanged at $169.05 as analysts maintain stable estimates based on consistent fair value metrics and minimal adjustments to key financial assumptions. What's in the News Pantene launches the Abundant & Strong Collection, a new three-step system designed to reduce hair loss by up to 85% and promote stronger, denser hair using antioxidant technology.
Narratiefupdate Nov 18

PG: Share Buybacks And New Guidance Will Support Steady Uptrend

Analysts have maintained Procter & Gamble's price target at $169.05 per share. There have been only minor adjustments to underlying valuation factors, supporting a steady outlook for the company.
Narratiefupdate Nov 03

PG: Share Buyback And Product Rollout Will Drive Long-Term Upside

Analysts have slightly raised their price target for Procter & Gamble to $169.05 from $168.64. They cite incremental improvements in revenue growth forecasts even as profit margin projections moderate.
Narratiefupdate Oct 20

Rising Consumer Confidence And Product Investment Will Expand US Markets

Analysts have slightly lowered their price target for Procter & Gamble from $170.95 to $168.64 per share. They cite modest reductions in projected revenue growth, which are partially offset by improved profit margins and valuation multiples.
Analyseartikel Aug 06

The Procter & Gamble Company (NYSE:PG) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

NYSE:PG 1 Year Share Price vs Fair Value Explore Procter & Gamble's Fair Values from the Community and select yours The...
User avatar
Nieuw narratief Jul 21

Procter & Gamble: A Dividend Giant Facing Slowing Growth

United States: 48.21%1-Year Revenue Growth = 4.65%
Analyseartikel Jun 27

The Procter & Gamble Company (NYSE:PG) Shares Could Be 21% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Procter & Gamble is US$200 based on 2 Stage Free Cash Flow to Equity Procter...
Seeking Alpha Apr 22

Procter & Gamble: Hold This Stodgy Stalwart

Summary Procter & Gamble is a global consumer product leader, with a strong market presence and consistent, albeit slow, growth in revenue and earnings. Despite being overvalued, PG's profitability remains robust, with reliable cash flow and a solid gross profit margin above industry medians. PG's valuation poses a risk, with a high PEG ratio indicating slow growth, yet it maintains a decent dividend yield and outpaces peers in performance. PG is a safe investment but lacks excitement; it's a hold due to its steady but lethargic growth and overvaluation concerns. Read the full article on Seeking Alpha

Winst- en omzetgroeiprognoses

NYSE:PG - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
6/30/202892,67917,99816,73522,40615
6/30/202789,54517,13415,45820,77921
6/30/202687,08216,46214,76118,86321
3/31/202686,71716,32315,02819,410N/A
12/31/202585,25916,16214,84819,070N/A
9/30/202584,93316,47314,94318,923N/A
6/30/202584,28415,68314,04417,817N/A
3/31/202583,92715,20615,02618,586N/A
12/31/202484,34615,19215,47118,969N/A
9/30/202483,90514,03115,85419,244N/A
6/30/202484,03914,59516,52419,846N/A
3/31/202484,06014,84516,16019,433N/A
12/31/202383,93314,48816,00219,208N/A
9/30/202383,26514,95414,58517,682N/A
6/30/202382,00614,37113,78616,848N/A
3/31/202380,96814,03812,20015,220N/A
12/31/202280,28113,99711,56614,603N/A
9/30/202280,46114,28713,19516,150N/A
6/30/202280,18714,46113,56716,723N/A
3/31/202279,61814,31413,95317,131N/A
12/31/202178,34614,23114,88517,972N/A
9/30/202177,13813,86615,24718,275N/A
6/30/202176,11814,03515,58418,371N/A
3/31/202174,87013,93316,32519,056N/A
12/31/202073,97513,58216,22719,033N/A
9/30/202072,47013,44715,12917,973N/A
6/30/202070,95012,76414,33017,403N/A
3/31/202070,3464,72513,51916,748N/A
12/31/201969,5944,553N/A16,201N/A
9/30/201968,7924,029N/A15,844N/A
6/30/201967,6843,634N/A15,242N/A
3/31/201967,09310,767N/A15,290N/A
12/31/201866,91210,523N/A15,126N/A
9/30/201866,8699,827N/A14,803N/A
6/30/201866,8329,485N/A14,867N/A
3/31/201866,4089,813N/A14,356N/A
12/31/201765,7329,838N/A14,043N/A
9/30/201765,1939,884N/A13,359N/A
6/30/201765,0589,862N/A12,753N/A
3/31/201765,0819,648N/A13,204N/A
12/31/201665,2319,427N/A13,442N/A
9/30/201665,2909,767N/A14,922N/A
6/30/201665,2999,676N/A15,435N/A
3/31/201665,7508,147N/A15,284N/A
12/31/201566,9258,213N/A15,558N/A
9/30/201568,5057,972N/A14,513N/A
6/30/201570,7497,920N/A14,608N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei PG ( 3.8% per jaar) ligt boven de spaarquote ( 3.5% ).

Winst versus markt: De winst van PG ( 3.8% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 16.8% per jaar).

Hoge groeiwinsten: De winst van PG zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van PG ( 3.1% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 11.7% per jaar).

Hoge groei-inkomsten: De omzet van PG ( 3.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen PG zal naar verwachting over 3 jaar hoog zijn ( 34.3 %)


Ontdek groeibedrijven

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/05/15 11:02
Aandelenkoers aan het einde van de dag2026/05/15 00:00
Inkomsten2026/03/31
Jaarlijkse inkomsten2025/06/30

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

The Procter & Gamble Company wordt gevolgd door 43 analisten. 21 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Christopher GrajaArgus Research Company
Lauren LiebermanBarclays
Lauren LiebermanBarclays